Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01912911 · ClinicalTrials.gov registry record
Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT01912911 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 60 participants.
The verdict
NCT01912911 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The investigators goal in this study is to examine the feasibility and efficacy of AliveCor iphone case monitoring device in monitoring patients after AF ablation by comparing transmissions using Alive Cor with transmissions from a traditional transtelephonic monitor (TTM). A secondary goal is to assess the ease of use of AliveCor device compared to traditional TTM system from the patient's perspective
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01912911
The ClinicalTrials.gov registry entry for NCT01912911 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01912911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01912911 about?
NCT01912911 is a clinical study titled "Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure". The investigators goal in this study is to examine the feasibility and efficacy of AliveCor iphone case monitoring device in monitoring patients after AF ablation by comparing transmissions using Alive Cor with transmissions from a traditional transtelephonic monitor (TTM). A secondary goal is to a...
What is the current status of trial NCT01912911?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2013-06. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01912911?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.